Literature DB >> 220290

A simple direct assay of 3',5'-cyclic nucleotide phosphodiesterase activity based on the use of polyacrylamide-bononate affinity gel chromatography.

C W Davis, J W Daly.   

Abstract

A rapid, simple, and direct assay for 3',5'-cyclic nucleotide phospho-diesterase activity is based on the effective separation of cyclic AMP, cyclic GMP or cyclic CMP from their corresponding 5'-nucleotides and nucleosides by chromatography on a polyacrylamide-boronate gel. The affinity of the boronate residue for cis-diols results in the retention of 5'nucleotides and nucleosides while 3',5'-cyclic nucleotides are not retained. The coelution of all 5'-nucleotides and nucleosides allows for the accurate assessment of phosphodiesterase activity in preparations contaminated by other purine metabolizing enzymes such as 5'-nucleotidases and nucleotide and nucleoside deaminases. Phosphodiesterase activity assayed by this means yields linear reaction kinetics with respect to time and amount of enzyme protein. Low blank values obtained allow for detection of as little as 2-3% conversion of substrate to product.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 220290

Source DB:  PubMed          Journal:  J Cyclic Nucleotide Res        ISSN: 0095-1544


  12 in total

1.  Potential therapeutic applications of phosphodiesterase inhibition in prostate cancer.

Authors:  Thomas K Hamilton; Nianping Hu; Klodiana Kolomitro; Erin N Bell; Donald H Maurice; Charles H Graham; D Robert Siemens
Journal:  World J Urol       Date:  2012-03-02       Impact factor: 4.226

2.  Expression and mutagenesis of the catalytic domain of cGMP-inhibited phosphodiesterase (PDE3) cloned from human platelets.

Authors:  K M Tang; E K Jang; R J Haslam
Journal:  Biochem J       Date:  1997-04-01       Impact factor: 3.857

3.  Adenosine 3',5'-phosphate phosphodiesterase and pheromone response in the yeast Saccharomyces cerevisiae.

Authors:  H H Liao; J Thorner
Journal:  J Bacteriol       Date:  1981-12       Impact factor: 3.490

4.  An improved assay of cyclic 3',5'-nucleotide phosphodiesterases with QAE-Sephadex columns.

Authors:  A C Bauer; U Schwabe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-03       Impact factor: 3.000

5.  The identification of a new cyclic nucleotide phosphodiesterase activity in human and guinea-pig cardiac ventricle. Implications for the mechanism of action of selective phosphodiesterase inhibitors.

Authors:  M L Reeves; B K Leigh; P J England
Journal:  Biochem J       Date:  1987-01-15       Impact factor: 3.857

6.  Activation of cGMP-stimulated phosphodiesterase by nitroprusside limits cAMP accumulation in human platelets: effects on platelet aggregation.

Authors:  N T Dickinson; E K Jang; R J Haslam
Journal:  Biochem J       Date:  1997-04-15       Impact factor: 3.857

7.  The effects of siguazodan, a selective phosphodiesterase inhibitor, on human platelet function.

Authors:  K J Murray; P J England; T J Hallam; J Maguire; K Moores; M L Reeves; A W Simpson; T J Rink
Journal:  Br J Pharmacol       Date:  1990-03       Impact factor: 8.739

8.  Cloning and expression of cDNA for a human low-Km, rolipram-sensitive cyclic AMP phosphodiesterase.

Authors:  G P Livi; P Kmetz; M M McHale; L B Cieslinski; G M Sathe; D P Taylor; R L Davis; T J Torphy; J M Balcarek
Journal:  Mol Cell Biol       Date:  1990-06       Impact factor: 4.272

9.  Effects of the human immunodeficiency virus-protease inhibitor, ritonavir, on basal and catecholamine-stimulated lipolysis.

Authors:  Diane C Adler-Wailes; Hanguan Liu; Faiyaz Ahmad; Ningping Feng; Constantine Londos; Vincent Manganiello; Jack A Yanovski
Journal:  J Clin Endocrinol Metab       Date:  2005-03-01       Impact factor: 5.958

Review 10.  Assays of cyclic nucleotides. A review of current techniques.

Authors:  B J Smith; M R Wales; M J Perry
Journal:  Appl Biochem Biotechnol       Date:  1993-06       Impact factor: 2.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.